SAM
UTHR icon

SEB Asset Management’s United Therapeutics UTHR Stock Holding History

SEB Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.79M Sell
12,523
-5,208
-29% -$2.93M 0.03% 408
2026
Q1 		$10.5M Buy
+17,731
New +$8.83M 0.04% 307

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

SEB Asset Management's UTHR Position: Q2 2026 in Review

SEB Asset Management reduced its United Therapeutics (UTHR) stake by 29% in Q2 2026, selling an estimated $2.93M and leaving 12,523 shares worth $6.79M. The position accounts for 0.03% of the portfolio, ranked #408.

SEB Asset Management first reported a position in UTHR in Q1 2026 and has held it in 2 quarters since. The position peaked at $10.5M in Q1 2026. 818 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • SEB Asset Management held 12,523 shares of United Therapeutics worth $6.79M as of Q2 2026.
  • SEB Asset Management sold 5,208 United Therapeutics shares in Q2 2026, an estimated $2.93M.
  • United Therapeutics made up 0.03% of SEB Asset Management's portfolio in Q2 2026, its #408 holding.
  • SEB Asset Management first reported a position in United Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • SEB Asset Management's United Therapeutics position peaked at $10.5M in Q1 2026.
  • 818 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on SEB Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.